Pharmabiz

Mankind Pharma Q2 revenue up 17%

Mankind Pharma, India’s fourth largest pharmaceutical Company announced its financial results for the second quarter and half year ended 30th September 2026. The company's revenue from operations ...
Pharmabiz

Eris Lifesciences Q2 PAT up 39%

Our Bureau, Mumbai Monday, October 26, 2026, 17:30 Hrs [IST] Eris Lifesciences Limited, a leading Indian branded formulations manufacturing compan ...
Pharmabiz

AIG Hospitals and Boston Scientific to set-up Centre of Excellence to strengthen access to therapeutic GI endoscopy

AIG Hospitals and Boston Scientific to set-up Centre of Excellence to strengthen access to therapeutic GI endoscopy: Our Bureau, Bengaluru Monday, October 26, 2026, 15:45 Hrs [IST ...
Pharmabiz

DSS Takara Bio-supported breast-cancer R&D lays strong foundation for future advances in treatment

DSS Takara Bio-supported breast-cancer R&D lays strong foundation for future advances in treatment: Our Bureau, Bengaluru Monday, October 26, 2026, 16:15 Hrs [IST] DSS Takara Bio ...
Pharmabiz

Innovent reports international phase 3 study of arcotatug tavatecan in gastric cancer meets dual primary endpoints of PFS and OS

Innovent reports international phase 3 study of arcotatug tavatecan in gastric cancer meets dual primary endpoints of PFS and OS: San Francisco Monday, October 26, 2026, 17:00 Hrs ...
Pharmabiz

MAHE sets up advanced BSL-3 facility for high-containment biomedical research

MAHE sets up advanced BSL-3 facility for high-containment biomedical research: Our Bureau, Bengaluru Monday, October 26, 2026, 16:30 Hrs [IST] Manipal Academy of Higher Education ...
Pharmabiz

WHO launches working papers on traditional medicine

The WHO Global Traditional Medicine Centre is launching a series of working papers designed to document and examine traditional, complementary and integrative medicine (TCIM) worldwide. The inaugural ...
Pharmabiz

CSO raises concern over inclusion of Dr Naresh Trehan in Committee to review pharma marketing practices

CSO raises concern over inclusion of Dr Naresh Trehan in Committee to review pharma marketing practices: Our Bureau, New Delhi Monday, October 26, 2026, 14:15 Hrs [IST] Raising co ...
Pharmabiz

Cipla's InvaGen facility receives zero Form 483 observations from US FDA

Cipla's InvaGen facility receives zero Form 483 observations from US FDA: Our Bureau, Mumbai Monday, October 26, 2026, 13:15 Hrs [IST] Cipla Ltd announced that an inspection was c ...
Pharmabiz

PHOSSCON focuses on 60% childhood cancer survival target by 2030

PHOSSCON focuses on 60% childhood cancer survival target by 2030: Our Bureau, Mumbai Monday, October 26, 2026, 13:45 Hrs [IST] India’s goal of achieving a childhood cancer survi ...
Pharmabiz

Nearly one-third of NSQs in CDSCO September alert originate from Himachal Pradesh pharma units

Nearly one-third of NSQs in CDSCO September alert originate from Himachal Pradesh pharma units: Our Bureau, Chennai Monday, October 26, 2026, 13:35 Hrs [IST] Nearly one-third of t ...
Pharmabiz

Healthium Medtech repositions SIRONIX to target the broader orthopaedic care segment

Healthium Medtech repositions SIRONIX to target the broader orthopaedic care segment: Our Bureau, Bengaluru Monday, October 26, 2026, 13:30 Hrs [IST] Healthium Medtech, a global m ...